Impact of CPAP treatment on cardiac biomarkers and pro-BNP in obstructive sleep apnea syndrome

Sleep and Breathing

Volumn 14, Issue 3, 2010, Pages 241-244

  Çifçi, Nilüfer ^a   Uyar, Meral ^a   Elbek, Osman ^a   Süyür, Hüseyin ^a   Ekinci, Erhan ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

CK; CK MB; CPAP; OSAS; Pro BNP; Troponin I

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CREATINE KINASE; CREATINE KINASE MB; TROPONIN I;

ADULT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HEART FUNCTION; HUMAN; MALE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SLEEP APNEA SYNDROME; TREATMENT DURATION;

ADULT; ASPARTATE AMINOTRANSFERASES; CONTINUOUS POSITIVE AIRWAY PRESSURE; CREATINE KINASE; CREATINE KINASE, MB FORM; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; POLYSOMNOGRAPHY; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; REFERENCE VALUES; SLEEP APNEA, OBSTRUCTIVE; TROPONIN I;

EID: 78650225485     PISSN: 15209512     EISSN: 15221709     Source Type: Journal    
DOI: 10.1007/s11325-009-0306-y     Document Type: Article

References (18)

1. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS (2004) Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350:655-663
2. Hukins CA (2006) Obstructive sleep apnea-management update. Neuropsychiatr Dis Treat 3:309-326
3. Goetze JP, Friis-Hansen L, Rehfeld JF, Nilsson B, Svendsen JH (2006) Atrial secretion of B-type natriuretic peptide. Eur Heart J 27:1648-1650
4. Grabowski M, Filipiak KJ, Karpinski G, Wretowski D, Rdzanek A, Huczek Z, Horszczaruk GJ, Kochman J, Ruduwski R, Opolski G (2004) Serum B-type natriuretic peptide levels on admission predict not only short term death but also angiographic success of procedure in patients with acute ST-elevation myocardial infarction treated with primary angioplasty. Am Heart J 148:655-662
5. Richards AM, Nicholls MG, Espiner EA, Lainchbury JG, Trouqhton RW, Elliott J, Frampton C, Turner J, Crozier IG, Yandle TG (2003) B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 107:2786-2792
6. Kaneko Y, Floras JS, Usui K, Plante J, Tkacova R, Kubo T, Ando S, Bradley TD (2003) Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 348:1233-1241
7. Anwaruddin S, Januzzi JL Jr, Baggish AL, Lewandrowski EL, Lewandrowski KB (2005) Ischemia-modified albumin improves the usefulness of standard cardiac biomarkers for the diagnosis of myocardial ischemia in the emergency department setting. Am J Clin Pathol 123:140-145
8. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, Solomon S, Spencer KT, St John Sutton M, Stewart W (2006) American society of echocardiography's nomenclature and standards committee; task force on chamber quantification; American college of cardiology echocardiography committee; American heart association; European association of echocardiography. European society of cardiology. Recommendations for chamber quantification. Eur J Echocardiog 7:79-108
9. American Academy of Sleep Medicine (1999) Sleep related breathing disorders in adults: recommendations for syndrome definition techniques in clinical research. The report of an American Academy of Sleep Medicine Task force. Sleep 22:667-689
10. Butt M, Dwivedi G, Khair O, Lip GY (2009) Obstructive sleep apnea and cardiovascular disease. Int J Cardiol (epub ahead of print)
11. McNicholas WT, Bonsigore MR, Management Committee of EU COST ACTION B26 (2007) Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 29:156-178
12. Maeder MT, Ammann P, Rickli H, Schoch OD, Korte W, Hürny C, Myers J, Münzer T (2008) N-terminal pro-B-type natriuretic peptide and functional capacity in patients with obstructive sleep apnea. Sleep Breath 12:7-16
13. Kaditis AG, Alexopoulos EI, Hatzi F, Kostadima E, Kiaffas M, Zakynthinos E (2006) Overnight change in brain natriuretic peptide levels in children with sleep-disordered breathing. Chest 130:1377-1384
14. Zhao ZH, Liu ZH, Luo Q, Xiong CM, Ni XH, Zhang J, Zhang S, Yang YJ (2006) Positive pressure ventilation treatment reduces plasma levels of amino terminal-probrain natriuretic peptide in congestive heart failure patients with sleep apnea. Circ J 70:572-574
15. Kita H, Ohi M, Chin K, Noquchi T, Otsuka N, Tsuboi T, Itoh H, Nakao K, Kuno K (1998) The nocturnal secretion of cardiac natriuretic peptides during obstructive sleep apnoea and its response to therapy with nasal continuous positive airway pressure. J Sleep Res 7:199-207
16. Hubnera RH, El Mokhtarib NE, Freitag S, Rauscheb T, Goderd R, Tirokeb A (2008) NT-proBNP is not elevated in patients with obstructive sleep apnoea. Respir Med 102:134-142
17. Kragelund C, Gronning B, Kober L, Hildebrandt P, Steffensen R (2005) N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 352:666-675
18. Gami AS, Svatikova A, Wolk R, Olson EJ, Duenwald CJ, Jaffe AS, Somers VK (2004) Cardiac troponin T in obstructive sleep apnea. Chest 125:2097-2100